TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
MIRAPHARM AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
100
|
77
|
73 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
25
|
2,996
|
41 |
EBITDA |
-7
|
17
|
39 |
Total assets |
1,380
|
3,071
|
182 |
Current assets |
1,158
|
2,851
|
92 |
Current liabilities |
35
|
13
|
19 |
Equity capital |
1,345
|
3,059
|
163 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
1
|
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
97.5%
|
99.6%
|
89.6% |
Turnover per employee | 100 | ||
Profit as a percentage of turnover |
25.0%
|
3890.9%
|
56.2% |
Return on assets (ROA) |
1.8%
|
97.6%
|
22.5% |
Current ratio |
3308.6%
|
21930.8%
|
484.2% |
Return on equity (ROE) |
1.9%
|
97.9%
|
25.2% |
Change turnover |
23
|
9
|
-8 |
Change turnover % |
30%
|
14%
|
-10% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.